Summary: During the initial evaluation of a patient with chest pain, many clinicians use the age, sex, and angina typicality-based pretest probabilities currently cited in professional society practice guidelines (guideline probabilities) to direct decisions for subsequent diagnostic testing and treatment. However, guideline probabilities were derived from patients clinically referred to invasive angiography and have not been validated in patients undergoing noninvasive testing. In this multinational study, the investigators analyzed the performance of guideline probabilities in 14 048 consecutive patients, including 8106 patients with chest pain, referred for coronary computed tomographic angiography. Computed tomographic angiography was used to determine the presence of angiographically significant coronary artery disease. In patients with chest pain, guideline probabilities significantly overestimated the overall prevalence of Ն50% diameter stenotic coronary artery disease (51% versus 18% observed by computed tomographic angiography) and Ն70% diameter stenotic coronary artery disease (42% versus 10%). Overestimation was particularly pronounced in patients with atypical angina and typical angina across all sex, age, and risk factor subgroups. The large differences between observed and predicted disease prevalence persisted in sensitivity analyses adjusted for potential inaccuracies of coronary computed tomographic angiography. Results from this study illustrate a major limitation in the practice of applying disease prevalence derived from invasive coronary angiography to populations undergoing initial noninvasive evaluation for coronary artery disease and highlight the need for updating probabilities of angiographically significant coronary artery disease in such populations.
Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve
Summary: Quantitative estimates of myocardial blood flow and coronary flow reserve integrate the fluid dynamic effects of epicardial atherosclerosis and microvascular function. The present study demonstrates that coronary flow reserve improves stratification of risk of cardiac and all-cause mortality beyond clinical risk factors, left ventricular ejection fraction, extent of myocardial ischemia and scar, and stress-induced left ventricular ejection fraction augmentation. Patients with coronary flow reserve Ͻ1.5 were at 5.6-fold increased risk of cardiac mortality compared with those with coronary flow reserve Ͼ2.0. Among patients whose clinical risk factors, left ventricular ejection fraction, and stress imaging findings placed them at intermediate risk of cardiac death (1%-3% per year), 35% were reclassified as either high risk (Ͼ3% cardiac mortality per year) or low risk (Ͻ1% cardiac mortality per year). These findings demonstrate that incorporation of coronary vasodilator function assessment into stress testing by quantification of coronary flow reserve improves risk stratification in patients with known or suspected coronary artery disease.
Conclusion:
Noninvasive quantitative assessment of coronary vasodilator function with positron emission tomography is a powerful, independent predictor of cardiac mortality in patients with known or suspected coronary artery disease and provides meaningful incremental risk stratification over clinical and gated myocardial perfusion imaging variables. 2 ness was greater in the reversible CP group than in the persistent CP group. Qualitatively rated severity of pericardial LGE was moderate or severe in 93% of the reversible CP group versus 33% of the persistent CP group. CMR LGE pericardial thickness Ն3 mm had 86% sensitivity and 80% specificity to predict reversibility. The reversible CP group also had a higher baseline C-reactive protein and erythrocyte sedimentation rate level than the persistent CP group. Anti-inflammatory therapy was associated with a reduction in pericardial LGE, C-reactive protein, and erythrocyte sedimentation rate in the reversible CP group but not in the persistent CP group. Our findings in this pilot observation suggest that reversible CP is associated with pericardial and systemic inflammation. Furthermore, anti-inflammatory therapy is associated with a reduction of pericardial and systemic inflammation, as well as pericardial thickness on CMR LGE imaging, with resolution of constrictive physiology and symptoms. Anti-inflammatory therapy should be considered in CP patients with these features before pericardiectomy. Our findings need to be validated by further studies in a larger number of patients.
Conclusions: Reversible CP was associated with pericardial and systemic inflammation. Anti-inflammatory therapy was associated with a reduction in pericardial and systemic inflammation and LGE pericardial thickness, with resolution of CP physiology and symptoms. Further studies in a larger number of patients are needed. 3 
Myocardial Structure, Function, and Scar in Patients With Type 1 Diabetes Mellitus
Summary: Type 1 diabetes mellitus is associated with a relatively high prevalence of cardiovascular disease and clinical and silent myocardial infarction compared with the nondiabetic population, leading to alterations in cardiac structure and function. In the present study, we evaluated the relationship of cardiovascular disease risk factors, including hemoglobin A 1c levels and diabetic nephropathy, to myocardial structure, function, and scar by cardiac MRI in 1017 patients of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. The DCCT/EDIC study is the first large-scale cohort of patients with type 1 diabetes mellitus. Patients had a mean clinical evaluation period of 22 years preceding cardiac magnetic resonance. We found that macroalbuminuria and mean hemoglobin A 1c (over Ϸ22 years of follow-up) were significant risk factors for alterations in left ventricular structure and function and for having myocardial scar. The prevalence of myocardial scar by cardiac magnetic resonance was 4.3% compared with only 1.4% in patients with clinically recognized myocardial infarction. The concordance of scar and clinical history was relatively low. These findings suggest that modifiable cardiovascular disease risk factors and glycemic control play a significant role in relationship to cardiovascular morbidity and mortality in patients with type 1 diabetes mellitus.
Conclusions: In addition to traditional cardiovascular disease risk factors, elevated mean hemoglobin A 1c and macroalbuminuria were significantly associated with alterations in left ventricular structure and function. The prevalence of myocardial scar was 4.3% in this subcohort of DCCT/EDIC participants with relatively preserved renal function. 4 
Acute Hypoglycemia Decreases Myocardial Blood Flow Reserve in Patients With Type 1 Diabetes Mellitus and in Healthy Humans
Summary: Hypoglycemia is a common problem that occurs in almost 20% of patients receiving intensive insulin therapy in hospital. Several studies have recently shown that hypoglycemia is associated with an increase in cardiovascular mortality. This association has been demonstrated in people with and without established coronary artery disease. Importantly, patients with acute coronary syndromes appear to have worse short-and long-term outcomes if they experience hypoglycemia in the acute phase of their presentation. The pathophysiological mechanism responsible for this association is not known. This present study examined the effects of hypoglycemia on myocardial blood flow (MBF) reserve using myocardial contrast echocardiography in subjects with type 1 diabetes mellitus and healthy control subjects. With the use of a 1-step hyperinsulinemic clamp technique, insulin-induced hypoglycemia decreased the MBF reserve in both patients with type 1 diabetes mellitus and healthy subjects. Furthermore, during hyperinsulinemic euglycemia, insulin induced a marked increase in peak MBF and MBF reserve, whereas hypoglycemia led to an increase in resting MBF and a decrease in peak MBF, thereby decreasing the MBF reserve overall. This effect was observed in both healthy individuals and patients with type 1 diabetes mellitus. We speculate from our results that alterations in MBF reserve may provide an explanation for the observed association between hypoglycemia and increased cardiovascular mortality in susceptible individuals.
Conclusions: Hypoglycemia decreases MBF reserve in both healthy humans and patients with diabetes mellitus. This finding may explain the association between hypoglycemia and increased cardiovascular mortality in susceptible individuals. 5 
Echocardiographic Markers of Elevated Pulmonary Pressure and Left Ventricular Diastolic Dysfunction Are Associated With Exercise Intolerance in Adults and Adolescents With Homozygous Sickle Cell Anemia in the United States and United Kingdom
Summary: Sickle cell disease, the most common inherited blood disorder in the United States, is a multisystem disease. It is characterized by episodes of acute illness; progressive organ damage in the spleen, joints, and kidneys as well as early mortality. Until recently, cardiopulmonary complications were not commonly recognized. With newer treatment options that prolong survival, clinical studies have shown that these patients also develop right and left heart dysfunction. Noninvasively measured elevations in pulmonary pressures and left ventricular diastolic dysfunction have been found to be independent predictors of mortality. In this observational study of 483 subjects with sickle cell disease, approximately one third had elevated pulmonary pressures by echocardiography. These patients had higher levels of hemolytic markers and serum erythropoietin and decreased renal function. Tissue Doppler-estimated filling pressures were used to assess diastolic dysfunction, and patients with a higher E/e' ratio were older, had higher body mass index and systemic blood pressure, and had lower hemoglobin concentration. They also had higher pulmonary systolic pressure. Sickle cell disease patients can develop significant exercise limitations. In this cohort, women and older individuals were more likely to have a shorter 6-minute walk distance. Pulmonary pressure elevations and diastolic dysfunction were also independent predictors of a lower 6-minute walk distance. Both of these risk markers are now recognized as important parameters of poor outcome in sickle cell disease and may help target patients for future treatment studies.
Conclusions: Echocardiography-estimated elevated pulmonary artery systolic pressure and LV lateral E/e' ratio were independently associated with poor exercise capacity in a large cohort of patients with sickle cell anemia. Controlled trials investigating whether strategies to prevent or delay pulmonary hypertension and/or LV diastolic dysfunction will improve exercise capacity and long-term outcomes in sickle cell anemia should be considered. 6 artery disease, eg, angina, can be challenging. Invasive coronary angiography (CA) carries tangible risks and does not provide tissue characterization. In this prospective study of 120 patients (powered to display noninferiority), late gadolinium enhanced cardiovascular magnetic resonance (LGE-CMR) showed equivalence to CA when determined against a gold standard consensus panel who considered data from all the investigations. Diagnoses ascribed by LGE-CMR and CA were also validated against clinical outcomes at a median of 3.7 years. LGE-CMR is ideally placed as a gatekeeper to CA because it is safer, uniquely provides biventricular function and tissue characterization data, and is economically viable.
LGE-CMR and CA were equivalent in diagnostic accuracy (97% versus 95%) and the data suggests that 73% of patients would have appropriately avoided CA, being spared the risks and costs of this investigation. Importantly, no patient with prognostically important coronary artery disease would have been denied CA and any subsequent revascularization as LGE-CMR had a negative predictive value of 100%. The data also suggests the need for a paradigm shift in the classification of patients with heart failure to reflect not just coronary anatomy, but also myocardial tissue characterization. This study therefore challenges the traditional dichotomy of ischemic versus nonischemic cardiomyopathy by revealing subgroups of patients with features of both ischemic and nonischemic etiologies.
Conclusion:
This study showed that LGE-CMR is a safe, clinically effective, and potentially economical gatekeeper to CA in patients presenting with heart failure of uncertain etiology. 7 
Detection of Intracoronary Thrombus by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction
Summary: Non-ST-segment-elevation acute coronary syndromes represent a growing clinical challenge in that most acute coronary syndromes or acute myocardial infarctions are not associated with ST-elevation myocardial infarction. Although patients with ECG changes indicative of ischemia and/or positive biomarkers of myocardial necrosis should be considered for early coronary angiography, differential diagnosis and treatment in the remaining spectrum of patients are challenging. This heterogeneous group includes a subgroup that would benefit from very early intervention (Ͻ24 hours), whereas others may have an improved outcome with initial medical optimization, including antiplatelet and antithrombotic treatment. Conventional clinical risk-scoring methods have not been able to clearly distinguish these groups. Because the majority of acute coronary syndromes are believed to be caused by rupture or erosion of an atherosclerotic plaque with subsequent intraluminal thrombosis resulting in partial or complete occlusion of a coronary artery, a technique that allows noninvasive detection of thrombus may further enhance risk stratification and allow treatment to be tailored in this high-risk population.
Conclusion:
Use of MR for direct thrombus imaging allows selective visualization of coronary thrombus in a patient population with a high probability of intracoronary thrombosis. 8 
Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy
Summary: Mutations in genes encoding proteins of the cardiac sarcomere are responsible for left ventricular hypertrophy, the diagnostic sine qua non of hypertrophic cardiomyopathy (HCM). However, whether other morphological features of HCM, seemingly unrelated to sarcomere mutations, are part of the disease phenotype is uncertain. We used cardiovascular magnetic resonance to characterize mitral valve abnormalities in a cohort of patients with HCM. Both anterior and posterior mitral valve leaflet lengths were greater among HCM patients compared with an age-and sex-matched control population (26Ϯ5 versus 19Ϯ5 mm, PϽ0.001; and 14Ϯ4 versus 10Ϯ3 mm, PϽ0.001, respectively), including more than one third of HCM patients in whom one or both of the mitral leaflets were substantially increased in length. In HCM patients, there was no relationship between mitral valve leaflet length and a number of clinical and demographic variables, including age, maximal left ventricular wall thickness, or left ventricular mass. In addition, elongated mitral valve leaflets were often the only clinical manifestation present in HCM family members carrying a sarcomere mutation without left ventricular hypertrophy and can represent the sole clinical marker of genotype-positive status. Elongated mitral valve leaflets were an important determinant of left ventricular outflow obstruction, particularly in patients in whom anterior mitral leaflet length exceeded 2-fold the transverse dimension of the outflow tract. These cardiovascular magnetic resonance-based observations show that structural abnormalities of the mitral valve represent a primary expression of the HCM phenotype and a morphological marker that may aid in diagnostic and management strategies, including optimal planning for septal reduction therapy.
Conclusions:
In HCM, mitral valve leaflets are elongated independently of other disease variables, likely constituting a primary phenotypic expression of this heterogeneous disease, and are an important morphological abnormality responsible for left ventricular outflow obstruction in combination with small outflow tract dimension. These findings suggest a novel role for cardiac magnetic resonance in the assessment of HCM. 9
Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug-Eluting Stent Implantation
Summary: We report the findings from optical coherence tomography (OCT) of in-stent neoatherosclerosis as a cause of drug-eluting stent failure. Optical coherence tomography was performed in a total of 50 lesions with angiographic in-stent restenosis (30 stable and 20 unstable angina). Optical coherence tomography-defined thin-cap fibroatheroma (TCFA)-containing neointima, thrombi, and neointimal rupture were identified in lesions with significant intimal hyperplasia (Ͼ50% of stent area). Median follow-up time was 32 months. Overall, 26 lesions (52%) had in-stent TCFA-containing neointima, and 29 (58%) had neointimal rupture. 
024).
Compared with stent Ͻ20 months after implantation (the best cut-off to predict TCFA-containing neointima), stent Ն20 months after implantation had a higher incidence of TCFAcontaining neointima (69% versus 33%, Pϭ0.012) and red thrombi (27% versus 0%, Pϭ0.007). Postintervention creatine kinase MB was significantly higher in intimal rupture versus no intimal rupture (Pϭ0.025). The rate of agreement between grayscale intravascular ultrasound and OCT for detecting intimal rupture was 50% and for detecting thrombus was 44%. In the virtual histology intravascular ultrasound subgroup (Nϭ32), the agreement between virtual histology intravascular ultrasound and OCT for identifying TCFAcontaining neointima was 78%. Thus, in-stent neoatherosclerosis may be an important mechanism of drug-eluting stent failure especially late after implantation.
Conclusions:
In-stent neoatherosclerosis may be an important mechanism of drug-eluting stent failure, especially late after implantation. 10 
Role of Pyruvate Dehydrogenase Inhibition in the Development of Hypertrophy in the Hyperthyroid Rat Heart: A Combined Magnetic Resonance Imaging and Hyperpolarized Magnetic Resonance Spectroscopy Study
Summary: The primary clinical significance of this article lies in the importance of gaining a better understanding of the underlying mechanisms resulting from hyperthyroidism. Using both noninvasive and novel techniques, we have thoroughly characterized the relationship between the metabolic and functional consequences of hyperthyroidism. By studying the metabolic perturbations associated with hyperthyroidism and using this information to devise a treatment regimen to improve metabolic flexibility in the hyperthyroid heart, we have uniquely shown that the associated cardiac hypertrophy can be reduced. We have also found that under conditions of plentiful energy supply, the heart is able to alter its response to maintain cardiac output. These findings are undoubtedly important, not only for this disease but also for other metabolic diseases affecting the heart. Furthermore, the potential to study the metabolic effects of hyperthyroidism and other cardiovascular diseases in humans with the hyperpolarized techniques presented here is clear. The first trials in humans with hyperpolarized pyruvate as a metabolic biomarker are imminent and offer many advantages over other forms of metabolic assessment such as including no radiation exposure and being a minimally invasive procedure. Metabolic studies with this technology can be integrated into existing MRI assessments of cardiac structure and function, as demonstrated here with a combined cine MRI and hyperpolarized magnetic resonance spectroscopy assessment.
Conclusions: This work has demonstrated that inhibition of glucose oxidation in the hyperthyroid heart in vivo is mediated by pyruvate dehydrogenase kinase. Relieving this inhibition can increase the metabolic flexibility of the hyperthyroid heart and reduce the level of hypertrophy that develops while maintaining the increased cardiac output required to meet the higher systemic metabolic demand. 11
Transcranial Doppler Detection of Cerebral Fat Emboli and Relation to Paradoxical Embolism: A Pilot Study
Summary: The fat embolism syndrome is a relatively common complication of long bone fractures. The classic triad of the syndrome includes petechiae, respiratory distress, and neurological dysfunction in the absence of other alternative explanations. The origin of the syndrome is related to the embolization of particulate matter, probably bone marrow, to different organs like skin, lungs, and brain. The risk factors to develop this syndrome are not yet clearly defined. In theory, the presence of an intracardiac right-to-left shunt (RLS), for example, a patent foramen ovale, can allow larger particles to bypass the lung and reach the brain. In an observational prospective study using transcranial Doppler, we observed that patients with long femoral fractures and intracardiac RLS were more likely to develop fat embolism syndrome compared with those without the RLS. The size and frequency of microembolic signals also predicted the occurrence of fat embolism syndrome in the context of RLS. Additionally, we monitored the patients intraoperatively, observing that during the surgical manipulation of the bones, there was an increase in the number and size of the microembolic signals. The clinical implications of the study are enormous if our findings are confirmed. The relatively easy identification of RLS with transcranial Doppler in the emergency room for patients with long bone fractures could become routine. In those in whom the RLS is identified, alternatives like closure of the RLS before surgery could be a potential treatment that needs to be explored with clinical trials. Summary: Cardiac MRI (CMR) is unique in its ability to provide assessment of hemodynamics, ventricular structure and function, valvular structure and function, myocardial viability, and stress perfusion. Various CMR-derived data are known to provide important prognostic information. However, the relative incremental prognostic value of 4 CMR components (vasodilator stress perfusion, myocardial delayed enhancement, aortic blood flow, and left ventricular volumes) is unclear. We followed up 908 patients for a mean of 2.6Ϯ1.2 years after they underwent combined 4-component CMR for suspicion of coronary stenosis and/or ischemia. In total, 101 cardiac events were observed, including 30 cardiac deaths, 36 noncardiac deaths, 5 nonfatal myocardial infarctions, and 19 late revascularizations. Normal 4-component CMR was followed by a 2.4% annual cardiac event rate (Ͻ0.4% for cardiac death) whereas abnormal CMR had an event rate of 5.6% to 7.0%. The risk of cardiac events increased significantly with increasing number of abnormal CMR components. After we adjusted for pre-CMR data, the addition of left ventricular ejection fraction, aortic flow, delayed enhancement, and stress perfusion data all added incremental prognostic power. CMR components were additive, not redundant, in predicting risk. Future studies may define how each CMR component is best applied in clinical practice.
Conclusions
Conclusions: CMR analysis of ventricular volume, aortic flow, myocardial viability, and stress perfusion all add incremental value for prediction of adverse events over pre-CMR data and can be combined to further enhance prognostication. Normal combined CMR confers a low risk of subsequent cardiac events. 13 
On T2* Magnetic Resonance and Cardiac Iron
Summary: Measurement of myocardial iron is key to the clinical management of patients at risk of iron-overload cardiomyopathy, which is a major killer in transfusion-dependent patients and others with errors of iron metabolism. This applies especially to the large cohort of ␤-thalassemia major patients, in whom iron accumulation leads to damage in the liver, heart, and endocrine organs. Myocardial iron is assessed clinically with the cardiovascular magnetic resonance relaxation parameter T2*. This study describes the calibration of cardiovascular magnetic resonance relaxation against human iron concentration and the iron distribution throughout the heart under conditions of iron overload. A strong correlation was observed between cardiovascular magnetic resonance relaxation measurements and biochemically derived tissue iron concentration in 12 postmortem human hearts from transfusion-dependent patients, leading to a clinical calibration equation of [Fe]ϭ45.0ϫ(T2*) Ϫ1.22 , where [Fe] is measured in milligrams per gram dry weight and T2* is measured in milliseconds. There was no systematic variation iron concentration throughout the heart, but higher iron levels were found in the epicardium than in the endocardium. The data also show that cardiovascular magnetic resonance measurements in the midventricular septum are very representative of whole-heart iron concentration, which validates the current clinical approach in widespread use. These data show that T2* cardiovascular magnetic resonance can be used to measure myocardial iron and validate its use as an end point in clinical trials for the improvement of efficacy of cardiac iron chelation treatment to prevent heart failure and death. This will significantly affect the health care of the many thousands of transfusion-dependent patients worldwide.
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Conclusions: These data detail the iron distribution throughout the heart in iron overload and provide calibration in humans for cardiovascular magnetic resonance R 2 * against myocardial iron concentration. The iron values are of considerable interest in terms of the level of cardiac iron associated with iron-related death and indicate that the heart is more sensitive to iron loading than the liver. The results also validate the current clinical practice of monitoring cardiac iron in vivo by cardiovascular magnetic resonance of the midseptum. 14 
Appropriate Use Criteria for Stress Single-Photon Emission Computed Tomography Sestamibi Studies: A Quality Improvement Project
Summary: In a previous study, we reported the application of the published American College of Cardiology Foundation appropriate use criteria for stress single-photon emission computed tomography (SPECT) imaging to patients at Mayo Clinic (Rochester, MN) in 2005 and 2006. This study reports the results of a subsequent internal quality improvement project focused on physician education, including a presentation at Medical Grand Rounds, a publication in the staff newsletter, meetings with physician administrators, and focused presentations to pertinent department/divisions of ordering physicians. Remeasurement of the appropriateness of SPECT studies was then performed using previously published methods. Unfortunately, the rate of inappropriate SPECT studies did not decrease as hoped but in fact showed a borderline increase (Pϭ0.06). Thus, this quality improvement project did not achieve the desired reduction in the rate of inappropriate stress SPECT studies in a single academic medical center. More extensive intervention may be necessary to achieve quality improvement with appropriateness criteria.
Conclusions: This quality improvement project, focused on feedback, physician education, and remeasurement, did not reduce the rate of inappropriate stress SPECT studies in a single academic medical center. Similar limited interventions focused on physician education alone may have limited benefit. More extensive intervention may be necessary to improve the quality of care with appropriateness criteria. 15 
Antihypertensive Treatment and Change in Blood Pressure Are Associated With the Progression of White Matter Lesion Volumes: The Three-City (3C)-Dijon Magnetic Resonance Imaging Study
Summary: Our study provides longitudinal population-based data on the relationship between blood pressure (BP) and cerebral white matter lesions (WMLs) in the elderly. WMLs are frequent in older individuals, and there is increasing evidence that they could be a marker of the risk of future stroke or dementia. In cross-sectional studies, elevated BP consistently relates to WMLs, but the relationship of baseline BP and changes in BP to the development of WML over time is less certain. In a longitudinal population-based study including 1319 subjects 65 to 80 years of age, we found that both baseline BP levels and change in BP levels over a 4-year follow-up were significantly associated with higher WML volume progression over 4 years. In addition, our data suggest that antihypertensive therapy was associated with a slowed progression of WML in individuals with high BP and untreated at study entry. Clinical trials are needed to determine whether white matter abnormalities are prevented or progression is slowed by antihypertensive therapy and serve as an early marker of successful treatment. Trials could also determine whether preventing WMLs with antihypertensive treatment can reduce the risk of dementia, which is an important goal in many increasingly older populations.
Conclusions: Our findings reinforce the hypothesis that hypertension is a strong predictor of WML and that adequate treatment may reduce the course of WML progression. Because WMLs are linked to both dementia and stroke risks, these results could have implications for future preventive trials. 16 
Relative Merits of Left Ventricular Dyssynchrony, Left Ventricular Lead Position, and Myocardial Scar to Predict Long-Term Survival of Ischemic Heart Failure Patients Undergoing Cardiac Resynchronization Therapy
Summary: The beneficial effects of cardiac resynchronization therapy on long-term survival are influenced by several pathophysiological factors. The present study demonstrated the relative merits of left ventricular (LV) dyssynchrony, LV lead position, and myocardial scar to predict long-term outcome of ischemic heart failure patients treated with cardiac resynchronization therapy. With speckle tracking radial strain analysis, the extent of LV dyssynchrony, site of latest mechanical activation, and presence of myocardial scar at the LV segment where the LV pacing lead is placed were evaluated. In addition, the LV lead position was derived from chest x-ray and was defined as concordant when the LV pacing lead coincided with the site of latest mechanical activation. Mean baseline LV radial dyssynchrony was 133Ϯ98 milliseconds. A concordant LV lead position was reported in 271 patients (68%), and the mean value of peak radial strain at the targeted segment was 18.9Ϯ12.6%. During a median follow-up of 21 months, 88 patients (22%) died. Larger LV radial dyssynchrony at baseline was an independent predictor of superior long-term survival (hazard ratio, 0.995 per 1-millisecond increment; Pϭ0.001), whereas a discordant LV lead position (hazard ratio, 2.086; Pϭ0.001) and myocardial scar in the segment targeted by the LV lead (hazard ratio, 2.913; PϽ0.001) were independent predictors of worse outcome. Addition of these 3 parameters yielded incremental prognostic value over the combination of clinical parameters. These data underscore the need for integrated evaluation that includes assessment of these 3 parameters to further improve patient selection and survival after cardiac resynchronization therapy.
Conclusions: Baseline LV radial dyssynchrony, discordant LV lead position, and myocardial scar in the region of the LV pacing lead were independent determinants of long-term prognosis in ischemic heart failure patients treated with cardiac resynchronization therapy. Larger baseline LV dyssynchrony predicted superior long-term survival, whereas discordant LV lead position and myocardial scar predicted worse outcome. 17 
Echocardiographic Evaluation of Hemodynamics in Patients With Decompensated Systolic Heart Failure
Summary: The assessment of hemodynamics in patients with acute decompensated heart failure can be of value in their treatment. We evaluated the accuracy of Doppler echocardiography in estimation of left and right ventricular hemodynamics in 79 patients with unstable heart failure. The technique had a good accuracy in the estimation of stroke volume, pulmonary artery systolic and diastolic pressure, and mean right atrial pressure. Several Doppler indices, including tissue Doppler, had good accuracy in identifying patients with pulmonary capillary wedge pressure Ͼ15 mm Hg. In addition, the recent American Society of Echocardiography/European Association of Echocardiography guidelines were highly accurate in identifying patients with increased wedge pressure. In 12 repeat studies, Doppler echocardiography readily detected the changes in mean wedge pressure as well as other hemodynamic changes.
Conclusions: Doppler echocardiography provides reliable assessment of right and left ventricular hemodynamics in patients with decompensated heart failure. 18 
Noninvasive Vascular Function Measurement in the Community: Cross-Sectional Relations and Comparison of Methods
Summary: Over the past years, several noninvasive measurement methods of vascular structure and reactivity have been implemented to assess cardiovascular function. We simultaneously measured flow-mediated dilation of the brachial artery, which reflects large artery reactivity, and finger pulse amplitude through volume and infrared plethysmography to assess microvascular function at baseline and after a 5-minute upper-arm occlusion in a population-based cohort. Vascular function measures showed low correlations among one another. The cardiovascular risk factors associated strongly with the most vascular function measures were age and sex followed by body mass index and indicators of blood pressure. Whereas baseline parameters were correlated with a broad spectrum of cardiovascular risk factors, the correlation with hyperemic response variables was weaker, and the overall variability explained by the risk factors was lower (maximum 15.4% for flow-mediated dilation). To understand the association of the 3 methods with cardiovascular disease outcomes, prospective data are needed to evaluate the value of structural and dynamic arterial changes for risk screening beyond classical risk factors.
Conclusions: Noninvasive measures of conduit artery and peripheral arterial function are modestly correlated, differ in their relation to classical cardiovascular risk factors, and may thus reflect different pathologies. 19 
Dynamic Changes of Edema and Late Gadolinium Enhancement After Acute Myocardial Infarction and Their Relationship to Functional Recovery and Salvage Index
Summary: Late gadolinium enhancement (LGE) and edema imaging are used to assess acute myocardial injury, area at risk, and salvaged myocardium after reperfusion. LGE is currently considered the gold standard for myocardial infarct visualization both in acute and chronic myocardial infarction and an accurate predictor of recovery of wall motion after revascularization. The present study shows that cardiac magnetic resonance features of acute myocardial infarction are dynamic and change for both LGE and edema. After revascularization, edema is shown to peak within the first week after reperfusion.
LGE performed in the first 24 hours does not necessarily indicate irreversible injury; our results show that 51% of the segments with transmural LGE at 24 hours after reperfusion recovered function at 6 months. A detailed knowledge of the early dynamic changes of both LGE and edema imaging is crucial in assessing final infarct size and myocardium salvage, especially when designing clinical trials using cardiac magnetic resonance.
Conclusions: Myocardial edema is maximal and constant over the first week after myocardial infarction, providing a stable window for the retrospective evaluation of area at risk. By contrast, myocardial areas with high signal intensity in LGE images recede over time with corresponding recovery of function, indicating that acutely detected LGE does not necessarily equate with irreversible injury and may severely underestimate salvaged myocardium. 20 
Prognostic Value of Coronary Computed Tomographic Angiography in Comparison With Calcium Scoring and Clinical Risk Scores
Summary: In recent years, coronary computed tomography angiography (CCTA) has emerged as a new noninvasive imaging modality for the detection and in particular exclusion of coronary artery stenosis. In addition CCTA has the unique advantage of not only depicting the vessel lumen but also the surrounding tissue and has been shown to detect noncalcified plaques. Some studies suggest an incremental value of the detection of these plaques for the prediction of subsequent cardiac events over clinical risk assessment and calcium scoring. In our study of 2223 mostly symptomatic patients undergoing CCTA for diagnostic purposes, we confirmed the good prognostic value of CCTA on the basis of findings of plaque and stenosis for major cardiac events, including death, myocardial infarction, and late coronary revascularization over 28 months. Moreover, we demonstrated that these findings are incremental in prediction of major cardiac events when compared with calcium scoring and clinical risk assessment (Morise score). The results of this study suggest that CCTA not only has excellent diagnostic value for the detection of stenosis but also has incremental prognostic value and particularly enables restratification of symptomatic patients at intermediate risk for obstructive coronary artery disease.
Conclusions:
In patients with suspected coronary artery disease, CCTA not only detects coronary stenosis but also improves prediction of cardiac events over and above conventional risk scores and calcium scoring. This may result in a reclassification of cardiovascular risk in a substantial proportion of patients. Summary: T2-weighted MRI has diagnostic and clinical utility for detecting myocardial edema in patients with known or suspected acute myocardial infarction. T2-weighted MRI also enables estimation of the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. The T2-weighted MRI method that is most widely used is dark-blood short tau inversion recovery (STIR). However, dark-blood STIR is prone to artifact from motion, subendocardial blood stasis, and technical issues with scan timing or surface coil sensitivity. All of these problems with dark-blood STIR may contribute to diagnostic uncertainty with this method. Based on recent technical developments, an alternative bright-blood T2-weighted MRI approach has emerged. Therefore, we compared the diagnostic accuracy of a new bright-blood T2-weighted MRI method with standard dark-blood STIR in patients with acute myocardial infarction. We found that compared with dark-blood STIR, brightblood T2-weighted MRI was associated with higher consensus agreements between observers for identification of myocardial edema and a higher rate of detection of the culprit coronary artery. The dark-blood method also underestimated the area at risk compared with infarct size. Our results support the use of bright-blood T2-weighted MRI instead of STIR for the assessment of myocardial edema.
Conclusions: Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood T2-weighted MRI. Additionally, darkblood T2-weighted MRI may underestimate area at risk and myocardial salvage. 22 
Mechanisms of Abnormal Systolic Motion of the Interventricular Septum During Left Bundle-Branch Block
Summary: In a majority of patients with left bundle-branch block, there is abnormal leftward motion of the interventricular septum during isovolumic contraction, often referred to as septal beaking and septal flash when applying M-mode echocardiography and tissue Doppler, respectively. It has not been definitely determined if this abnormal motion is due to active septal contraction or if it is represents passive motion caused by an early rise in right ventricular pressure that pushes the septum leftward. The recent interest in quantification of dyssynchrony in patients who are candidates for cardiac resynchronization therapy has highlighted the importance of this distinction: If preejection septal motion is due to active contraction, it reflects timing of septal activation and should be included in left ventricular dyssynchrony assessment. If the motion is passive, however, it should not be used for timing of septal activation. The aim of this study was to differentiate between these mechanisms. In an animal model of left bundle-branch block, myocardial shortening was measured by sonomicrometry, electric propagation by implanted myocardial electrodes, and right and left ventricular pressures by micromanometers. The report concludes that the abnormal septal motion during preejection is a result of active septal contraction, unopposed by the late-activated left ventricular lateral wall. Whereas the magnitude of the preejection septal motion was modulated by changes in right and left ventricular loading, onset of septal shortening reflected septal activation regardless of loading conditions. These experimental data suggest that onset of preejection shortening rather than ejection phase indices should be used for timing of septal activation.
Conclusions: Leftward preejection motion of the septum during left bundle-branch block is mainly a result of active septal contraction, whereas alterations in diastolic ventricular pressures modulate the amplitude of this motion. The findings imply that the preejection phase should be included when assessing left ventricular dyssynchrony. 23 
Incremental Prognostic Value of Cardiac Computed Tomography in Coronary Artery Disease Using CONFIRM: COroNary Computed Tomography Angiography Evaluation for Clinical Outcomes: An InteRnational Multicenter Registry
Summary: The prognostic value of cardiac computed tomographic angiography has been demonstrated in single center studies; however, large multicenter studies validating the prognostic value of CCTA and LVEF are lacking. Using a large international multicenter registry (CONFIRM Registry) of 27 125 patients, we sought to confirm the independent and incremental prognostic value of coronary artery disease (CAD) severity measured using 64-slice CT over left ventricular ejection fraction (LVEF) and clinical variables. Multivariable analysis of 14 064 patients, confirmed that LVEF Ͻ50% (hazard ratio, 2.74 [2.12-3.51]) and CAD severity (hazard ratio, 1.58; 95% confidence interval, 1.42-1.76) were predictors of all-cause mortality and CAD severity had incremental value over LVEF and clinical variables. Our results demonstrate that CCTA measures of CAD severity and LVEF have independent prognostic value. Incorporation of CAD severity provides incremental value for predicting all-cause death over routine clinical predictors and LVEF in patients with suspected obstructive CAD.
Conclusions: Our results demonstrate that CCTA measures of CAD severity and LVEF have independent prognostic value. Incorporation of CAD severity provides incremental value for predicting all-cause death over routine clinical predictors and LVEF in patients with suspected obstructive CAD. 24 
